Wedbush raises Palantir stock price target to $90

Wedbush analyst Robert Driscoll reiterated a Hold rating on Zentalis Pharmaceuticals (ZNTL – Research Report) today and set a price target of ...
Dan Ives, Wedbush, joins 'Fast Money' to talk the U.S.' infrastructure investment plans and what it means for Big Tech.
TikTok resumes operations in the U.S. after President-elect Trump promises a 90-day extension to the divest-or-sell law, ...
Wedbush Securities hiked its base case price target on Tesla (NASDAQ:TSLA) to $550 from $515 on its view that the golden age ...
Zentalis Pharmaceuticals Inc (ZNTL) stock saw a decline, ending the day at $2.22 which represents a decrease of $-0.08 or -3.48% from the prior close of $2.3. The stock opened at $2.27 and touched a ...
Wedbush reduced their FY2024 earnings per share estimates for shares of Neurocrine Biosciences in a report released on ...
Potential TikTok buyers are lining up as President Trump and the Chinese government show heightened interest in striking a ...
Shares of Nvidia, Microsoft, Oracle, and other AI-related companies surged Wednesday after the Trump administration’s ...
Wedbush Securities analysts predicted about 20% of the world’s population will access AI through an Apple device over the coming years.